Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Hepatitis

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 39 articles: HTML format

Single Articles

January 2026
1. ELFEKI MA, Zhang W, Dunn W, Arab JP, et al
   Increasing Liver Transplant Listings for Alcohol-Associated Hepatitis in Younger Patients with High MELD Scores and Excellent Performance Status.
   Dig Dis Sci. 2026 Jan 27. doi: 10.1007/s10620-026-09694.
   PubMed     Abstract available
   
   
   
2. KESER MF, Keser ZB, Yurdaydin C, Yilmaz S, et al
   Long-Term Post-transplant Outcomes in Patients with Hepatitis D Virus Infection at a High-Volume Liver Transplant Center.
   Dig Dis Sci. 2026 Jan 6. doi: 10.1007/s10620-025-09654.
   PubMed     Abstract available
   
   
   November 2025
3. HAN F, Cui C, Cui J, Zang S, et al
   Silencing Clusterin Could Attenuate the Cell Properties of HCV Core Protein-Expressing HCC Cell Line.
   Dig Dis Sci. 2025 Nov 25. doi: 10.1007/s10620-025-09560.
   PubMed     Abstract available
   
   
   September 2025
4. CHEN Y, Feng H, Bao Y, Yan M, et al
   Cost-Effectiveness of Risk-Score-Based Surveillance Strategies for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
   Dig Dis Sci. 2025 Sep 27. doi: 10.1007/s10620-025-09419.
   PubMed     Abstract available
   
   
   July 2025
5. GRANITO A, Muratori P, Czaja AJ
   Autoimmune Hepatitis Treatment: Can Low-Dose Steroids Be Generalized?
   Dig Dis Sci. 2025 Jul 25. doi: 10.1007/s10620-025-09256.
   PubMed     Abstract available
   
   
   
6. PASTA A, Pieri G, Giannini EG
   Autoimmune Hepatitis-Associated Hepatocellular Carcinoma: Clarifying the Evidence-A Reply.
   Dig Dis Sci. 2025 Jul 24. doi: 10.1007/s10620-025-09243.
   PubMed    
   
   
   June 2025
7. AHMAD B, Arshad A, Muhammad N
   Comment on "Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis".
   Dig Dis Sci. 2025 Jun 26. doi: 10.1007/s10620-025-09201.
   PubMed    
   
   
   
8. EKPENDU AC, Asghar MS, Patel R, Avalos ME, et al
   Trends in Mortality Caused by Hepatitis C Virus in the United States Population: A Retrospective Cross-Sectional Study Using the CDC WONDER Database.
   Dig Dis Sci. 2025 Jun 18. doi: 10.1007/s10620-025-09161.
   PubMed     Abstract available
   
   
   
9. AGGARWAL A, Swaroop S, Biswas S, Mehta S, et al
   Efficacy, Safety and Long-Term Clinical Outcomes of Low-Dose Versus High-Dose Prednisolone Induction in Autoimmune Hepatitis: A Propensity Score-Matched Analysis.
   Dig Dis Sci. 2025 Jun 17. doi: 10.1007/s10620-025-09129.
   PubMed     Abstract available
   
   
   
10. MARTIN MT, Saiyad Z, Mordarski G, Pan A, et al
    Didactic Education on Viral Hepatitis Elimination within Medical School Curricula in the United States.
    Dig Dis Sci. 2025 Jun 11. doi: 10.1007/s10620-025-09111.
    PubMed     Abstract available
    
    
    May 2025
11. OWAIS M, Kumar D, Anjum A, Kumar J, et al
    Clinical Insights on Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09124.
    PubMed    
    
    
    
12. FATIMA N, Usmani WA
    Long-Term Follow-Up of Patients with Cryoglobulinemia After Successful Treatment of Chronic C Virus Hepatitis.
    Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09119.
    PubMed     Abstract available
    
    
    
13. PASTA A, Pieri G, Plaz Torres MC, Missale G, et al
    Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2025 May 3. doi: 10.1007/s10620-025-09064.
    PubMed     Abstract available
    
    
    April 2025
14. ELTHES BZ, Vitalis Z, Papp M, Tornai T, et al
    Long Term Follow-Up of Patients with Cryoglobulinemia After Successful Treatment of Chronic C Virus Hepatitis.
    Dig Dis Sci. 2025 Apr 10. doi: 10.1007/s10620-025-09033.
    PubMed     Abstract available
    
    
    March 2025
15. HABASH N, Absah I
    Hepatitis B Risk in Vaccinated Patients with Celiac Disease - Do Titers Matter?
    Dig Dis Sci. 2025 Mar 20. doi: 10.1007/s10620-025-08998.
    PubMed    
    
    
    February 2025
16. SRINATH VBS, Shahid F, Saddique MN, Mumtaz H, et al
    Cholestatic Phenotype in Autoimmune Hepatitis: A Rare Presentation.
    Dig Dis Sci. 2025 Feb 28. doi: 10.1007/s10620-025-08927.
    PubMed    
    
    
    
17. JOSSEN J, Lebwohl B, Soderling J, Duberg AS, et al
    No Increased Risk of Hepatitis B Virus Infection in Patients with Celiac Disease: A Population-Based Study.
    Dig Dis Sci. 2025 Feb 21. doi: 10.1007/s10620-025-08878.
    PubMed     Abstract available
    
    
    
18. PAK K, Sachar R, Saab S
    Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States.
    Dig Dis Sci. 2025 Feb 20. doi: 10.1007/s10620-025-08909.
    PubMed     Abstract available
    
    
    November 2024
19. DE LA TORRE SA JR, Morcos M, Saab S, Shetty A, et al
    Alcohol-Associated Hepatitis: Short- and Long-Term Management.
    Dig Dis Sci. 2024 Nov 22. doi: 10.1007/s10620-024-08705.
    PubMed     Abstract available
    
    
    
20. CON D, Clayton-Chubb D, Tu S, Lubel JS, et al
    Predicting Immune Flares in Untreated Chronic Hepatitis B Patients Using Novel Risk Factors and the FLARE-B Score.
    Dig Dis Sci. 2024 Nov 18. doi: 10.1007/s10620-024-08746.
    PubMed     Abstract available
    
    
    
21. XIAO Y, Shi M, Xiao J, Xie X, et al
    Dynamic Profiles of Internal m7G Methylation on mRNAs in the Progression from HBV Infection to Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Nov 18. doi: 10.1007/s10620-024-08736.
    PubMed     Abstract available
    
    
    September 2024
22. RULE JA, Ajayi F, James LP, Tujios SR, et al
    Differentiating Ischemic Hepatitis from Acetaminophen Overdose in Acute Liver Failure: Role of Acetaminophen Adducts-Ischemic Hepatitis vs Acetaminophen Overdose.
    Dig Dis Sci. 2024 Sep 2. doi: 10.1007/s10620-024-08602.
    PubMed     Abstract available
    
    
    July 2024
23. MAKOVICH Z, Radosavljevic I, Chapyala S, Handley G, et al
    Rationale for Hepatitis C Virus Treatment During Hematopoietic Stem Cell Transplant in the Era of Novel Direct-Acting Antivirals.
    Dig Dis Sci. 2024 Jul 11. doi: 10.1007/s10620-024-08541.
    PubMed     Abstract available
    
    
    
24. CHANG CW, Hsu WF, Tseng KC, Chen CY, et al
    Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.
    Dig Dis Sci. 2024 Jul 4. doi: 10.1007/s10620-024-08512.
    PubMed     Abstract available
    
    
    June 2024
25. LEY D, Lazarus S, Forati AM, Farraye FA, et al
    High Rates of Seroprotection to Hepatitis B After a Hepatitis B Challenge Dose in Previously Vaccinated Patients with Inflammatory Bowel Disease on Immunosuppressive Therapy.
    Dig Dis Sci. 2024 Jun 21. doi: 10.1007/s10620-024-08527.
    PubMed     Abstract available
    
    
    
26. HEALEY MA, Ramalingam G, Hang Y, Smirnova E, et al
    Utility of Lille Score in Predicting 30-Day Survival in Steroid-Treated Alcohol-Associated Hepatitis.
    Dig Dis Sci. 2024 Jun 18. doi: 10.1007/s10620-024-08479.
    PubMed     Abstract available
    
    
    May 2024
27. PAN CW, Guifarro D, Poudel A, Abboud Y, et al
    Racial Disparities in Alcoholic Hepatitis Hospitalizations in the United States: Trends, Outcomes, and Future Projections.
    Dig Dis Sci. 2024 May 29. doi: 10.1007/s10620-024-08462.
    PubMed     Abstract available
    
    
    April 2024
28. LEE DU, Bhowmick K, Kolachana S, Schuster K, et al
    Inpatient Cost Burdens of Treating Chronic Hepatitis B in US Hospitals: A Weighted Analysis of a National Database.
    Dig Dis Sci. 2024 Apr 24. doi: 10.1007/s10620-024-08448.
    PubMed     Abstract available
    
    
    
29. CHANG ML, Le PH, Chen WT, Chen TD, et al
    Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08439.
    PubMed     Abstract available
    
    
    
30. PEARLMAN BL
    Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
    Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
    PubMed     Abstract available
    
    
    February 2024
31. CON D, Tu S, Clayton-Chubb D, Lubel JS, et al
    Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
    Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08354.
    PubMed     Abstract available
    
    
    
32. HUANG J, Cheng C, Li K, Zhu C, et al
    Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08258.
    PubMed     Abstract available
    
    
    December 2023
33. POOLA S, Kratzer M, Sewell K, Tillmann HL, et al
    Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy.
    Dig Dis Sci. 2023;68:4511-4520.
    PubMed     Abstract available
    
    
    November 2023
34. SUN Y, Lu M, Feldman R, Saul M, et al
    Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
    PubMed     Abstract available
    
    
    October 2023
35. JINDAL A, Sharma MK, Vijayaraghavan R, Sm S, et al
    Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
    PubMed     Abstract available
    
    
    
36. BUI HH, Nguyen ST, Phan ST, Nguyen KM, et al
    Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2023 Oct 20. doi: 10.1007/s10620-023-08143.
    PubMed     Abstract available
    
    
    
37. KILANI Y, Arshad I, Aldiabat M, Bhatija RR, et al
    Autoimmune Hepatitis and Obstetrical Outcomes: A Nationwide Assessment.
    Dig Dis Sci. 2023 Oct 10. doi: 10.1007/s10620-023-08129.
    PubMed     Abstract available
    
    
    
38. EVON DM, Lin HS, Khalili M, Wahed AS, et al
    Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial.
    Dig Dis Sci. 2023 Oct 7. doi: 10.1007/s10620-023-08108.
    PubMed     Abstract available
    
    
    September 2023
39. CZAJA AJ
    Introducing Molecular Chaperones into the Causality and Prospective Management of Autoimmune Hepatitis.
    Dig Dis Sci. 2023 Sep 27. doi: 10.1007/s10620-023-08118.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum